Neurology News

LAS VEGAS — To address patient need, affordability and physician-assisted treatment plans, a range of prevention therapies should be offered to those with migraines, according to a presenter at BRAINWeek 2022.

SAN DIEGO – One compound from Annovis Bio is showing success in phase 2 clinical trials for both Alzheimer’s disease and Parkinsons’ disease, a company executive said at the Alzheimer’s Association International Conference.

LAS VEGAS — Central neuropathic pain can be challenging to treat, but several pharmacologic and nonpharmacologic options are available, according to a presenter at BRAINWeek 2022.

Often, after speaking about taxes at a medical conference, we are approached by a physician attendee who has read that billionaires, like Warren Buffet and Elon Musk, pay less taxes than they do and they wonder how that can be.

Higher levels of the inflammatory marker C-reactive protein predicted lower reported cognitive function among older breast cancer survivors, according to study results published in Journal of Clinical Oncology.

The FDA has approved Relyvrio, an oral, fixed-dose combination therapy for the treatment of adults with ALS, Amylyx Pharmaceuticals Inc. announced in a press release.

The NIH has awarded a $10.7 million 5-year renewal grant to Cleveland Clinic to expand a national research consortium focused on improving the diagnosis and treatments for dementia with Lewy bodies.

LAS VEGAS — Disparities in stroke care, particularly among underrepresented populations, can be overcome through educational efforts in both the health care system and at the community level, said a presenter at BRAINWeek 2022.

An LDL target of less than 70 mg/dL with ezetimibe plus statin therapy was associated with lower risk for subsequent events after stroke/transient ischemic attack at 5 years vs. a target between 90 mg/dL and 110 mg/dL, researchers reported.

Emotional exhaustion has increased about 10% for all types of health care workers since the beginning of the COVID-19 pandemic, suggesting that current resources are not enough to improve their well-being, according to researchers.